Table 4. Estimated overall survival probability according to LAMC2 (cut-off: 109.55 ng ml−1) and CA 125 (cut-off: 35 U ml−1) status (high: (+), low: (−)). Cox Hazard Ratios are also included.
| Overall survival | LAMC2(−) CA 125(−) (N=28) | LAMC2(+) CA 125(−) (N=24) | LAMC2(−) CA 125(+) (N=28) | LAMC2(+) CA 125(+) (N=32) |
|---|---|---|---|---|
| 1 Year | 90.6% | 78.0% | 91.3% | 54.7% |
| 2 Years | 90.6% | 46.9% | 76.0% | 30.3% |
| 3 Years | 60.4% | 23.4% | 41.6% | 20.2% |
| Hazard ratio | 1.00 | 1.99 | 3.76 | 7.47 |
Abbreviations: CA 125, cancer antigen 125.